Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Biomarker-Based Immunoassays Market Forecast Highlighting Growth From $7.37 Billion To $11.55 Billion

The biomarker-based immunoassays market has experienced considerable expansion in recent years. This market is expected to increase from $6.6 billion in 2025 to $7.37 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.6%. The historical growth of this market can be attributed to factors such as the rising incidence of chronic diseases, which has intensified the demand for early diagnostic testing, the expanded application of enzyme linked immunosorbent assay in clinical laboratories, improvements in hospital diagnostic infrastructure and laboratory networks, the increasing use of antibody based detection techniques in research applications, and the formulation of standardized biomarker identification methods in biomedical research.

The biomarker-based immunoassays market is projected to experience substantial expansion in the coming years, reaching a valuation of $11.55 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.9%. This projected growth during the forecast period is fueled by several factors, including the escalating demand for personalized medicine and precise diagnostics, the greater incorporation of AI and machine learning into biomarker analysis, the wider embrace of multiplex and high-throughput immunoassay techniques, the broader deployment of point-of-care diagnostic testing in distant healthcare environments, and increased financial commitments to pharmaceutical research and drug discovery initiatives. Key trends anticipated in this period encompass AI-powered biomarker interpretation alongside predictive disease modeling to improve diagnostic precision, multiplex immunoassay platforms allowing for the concurrent identification of numerous biomarkers, cloud-based immunoassay systems for consolidated management of diagnostic data, laboratory automation combined with robotic sample handling for efficient high-throughput immunoassay analysis, and advanced point-of-care immunoassay devices for swift clinical diagnoses.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample_request?id=11186796&type=smp

Biomarker-Based Immunoassays Market Growth Factors Supporting Long-Term Expansion

The escalating number of oncology cases is anticipated to fuel the expansion of the biomarker-based immunoassays market. Oncology cases, defined as the occurrence of cancers stemming from abnormal and uncontrolled cellular growth that can disseminate to various body parts, are on the rise primarily due to aging populations. The risk of developing cancer increases substantially with age, and longer life expectancies lead to a greater number of diagnosed cases. Biomarker-based immunoassays are instrumental in managing oncology cases by enabling early detection, meticulous monitoring of disease progression, and guiding personalized treatment decisions through the accurate identification of cancer-specific biomarkers. For example, in February 2024, the World Health Organization projected over 35 million new cancer cases by 2050, marking a 77% increase from the estimated 20 million cases in 2022. Therefore, the increasing incidence of oncology cases is a significant driver for the growth of the biomarker-based immunoassays market.

Biomarker-Based Immunoassays Market Categorization By Product Type And Application

The biomarker-based immunoassays market covered in this report is segmented –

1) By Product: Consumables, Instruments And Analyzers, Reagents And Kits, Services

2) By Biomarker Type: Protein Biomarkers, Hormone Biomarkers, Cardiac Biomarkers, Cancer Biomarkers, Infectious Disease Biomarkers, Neurological Biomarkers, Autoimmune Disease Biomarkers

3) By Technology: Chemiluminescence, Enzyme Linked Immunosorbent Assay, Fluorescence, Multiplex, Radioimmunoassay, Other Technologies

4) By Application: Oncology Diagnostics, Cardiology Diagnostics, Infectious Disease Testing, Endocrinology Testing, Autoimmune Disease Testing, Neurology Diagnostics, Drug Discovery And Development

5) By End-User: Clinical Diagnostic Laboratories, Pharmaceutical Research And Development, Contract Research Organizations, Hospitals And Clinics, Academic Research Institutes

Subsegments:

1) By Consumables: Pipette Tips, Microplates, Sample Containers, Microcentrifuge Tubes, Reagent Reservoirs, Disposable Pipettes

2) By Instruments And Analyzers: Enzyme Linked Immunosorbent Assay Analyzers, Chemiluminescence Immunoassay Analyzers, Fluorescence Immunoassay Systems, Multiplex Assay Platforms, Radioimmunoassay Instruments, Automated Immunoassay Analyzers

3) By Reagents And Kits: Enzyme Linked Immunosorbent Assay Kits, Chemiluminescence Immunoassay Reagents, Fluorescence Immunoassay Reagents, Multiplex Assay Kits, Radioimmunoassay Kits, Controls And Standards

4) By Services: Assay Development Services, Sample Testing Services, Data Analysis Services, Technical Support Services, Clinical Trial Support Services, Training And Consultation Services

Biomarker-Based Immunoassays Market Industry Trends Shaping Future Revenue Growth

Key companies operating within the biomarker-based immunoassays market are prioritizing the development of innovative solutions, such as ultrasensitive immunoassay platforms, to facilitate the early and precise detection of low-abundance biomarkers. These ultrasensitive immunoassay platforms represent advanced diagnostic systems engineered to identify exceptionally low concentrations of biomarkers with high accuracy and specificity, thereby enabling earlier disease detection, enhanced diagnostic precision, and improved monitoring of disease progression compared to traditional assays. For instance, in July 2025, Spear Bio Inc., a US-based biotechnology company, launched SPEAR UltraDetect, a next-generation ultrasensitive immunoassay solution specifically designed to improve biomarker detection in neurodegenerative disease research. This platform employs proprietary homogeneous assay technology that eliminates the need for wash steps, a departure from traditional heterogeneous immunoassays, thus allowing for faster and more streamlined workflows. It possesses the capability to detect protein biomarkers at attomolar concentrations using as little as 1 µL of sample, significantly enhancing sensitivity and efficiency. The solution incorporates assays targeting critical neurological biomarkers including pTau217, pTau231, GFAP, and NfL, which support early and accurate disease analysis.

Biomarker-Based Immunoassays Market Company Landscape And Strategic Competition

Major companies operating in the biomarker-based immunoassays market are Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Eurofins Scientific SE, Bio-Rad Laboratories Inc., QIAGEN N. V., Tecan Trading AG, Autobio Diagnostics Co. Ltd., Promega Corporation, Sekisui Diagnostics LLC, Boditech Med Inc., Dynex Technologies Inc., NanoEntek Inc., J. Mitra & Co. Pvt. Ltd., ALPCO Diagnostics LLC, Micropoint Bioscience Inc., Coris BioConcept, MiCo BioMed Co. Ltd., Abionic SA, ANP Technologies Inc., Axela Inc., Epitope Diagnostics Inc., MedMira Inc., Nanomix Inc.

Access The Complete Biomarker-Based Immunoassays Market Report:

https://www.thebusinessresearchcompany.com/report/biomarker-based-immunoassays-market-report

Biomarker-Based Immunoassays Market Regional Outlook: Where Are The Largest Opportunities Located?

North America was the largest region in the biomarker-based immunoassays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarker-based immunoassays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model